key articles
CEM 2012: are lasers replacing resectoscopes in BPE surgery?
Friday, 12 October 2012- The question whether the laser is steadily replacing the resectoscope on the treatment of benign prostate enlargement (BPE) was examined in a head-to-head debate at the 12th Central European Meeting...
By Joel Vega
NSAID use shows no protective benefit to reduce risks for BPH/LUTS
Wednesday, 11 April 2012- Accumulating evidence suggests that inflammation may contribute to the development of BPH and LUTS. Therefore, it is plausible that anti-inflammatory agents, such as aspirin and other NSAIDs, may reduce...
Filed by: JV
Safety and efficacy of eraser laser enucleation of the prostate
Tuesday, 25 October 2011- A group of Austrian researchers conducted a study with the aim to ascertain the safety and efficacy of the 1,318 nm diode Eraser laser (Rolle and Rolle, Salzburg, Austria) for transurethral enucleation...
Edited by: JV
Serum C-reactive protein levels are linked to residual urgency symptoms in BPH patients
Wednesday, 19 October 2011- Urinary urgency is a common and bothersome symptom in patients with benign prostatic hyperplasia (BPH); this symptom may persist even after medical treatment.
Chronic inflammation has been reported...
Edited by: JV
Saw palmetto fails to reduce enlarged prostate symptoms
Thursday, 29 September 2011- Doses of saw palmetto extract up to three times the standard did not reduce lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), according to a randomised,...
Edited by: JV
BPH patients undergoing treatment have higher risk to develop PCa
Tuesday, 27 September 2011- Patients who are hospitalised or have surgery for benign prostatic hyperplasia (BPH) appear to be at higher risk for developing prostate cancer, researchers said here.
In a study utilising a large...
Edited by: JV
Aussie study shows safety of Prostatic Urethral Lift in BPH patients
Wednesday, 11 May 2011- Most surgical treatments for benign prostatic hyperplasia procedural involve the removal or destruction of prostate tissue and these approaches are commonly associated with treatment related morbidity....
Edited by: JV
Clinical efficacy of alpha1-Adrenargic Receptor Antagonist in BPH patients
Wednesday, 28 July 2010- K. Kadekawa and colleagues assessed the clinical efficacy and safety of 75 mg/day of naftopidil, an alpha1-adrenargic receptor antagonist in patients with benign prostatic hyperplasia (BPH). They...
Edited by: JV
Combination therapy more effective for enlarged prostate
Thursday, 4 March 2010- Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT...
Edited by: ES
CombAT study shows superiority of combined treatment over monotherapy
Tuesday, 29 September 2009- Combination therapy with dutasteride and tamsulosin provides significantly greater benefit than either monotherapy for various patient-reported outcomes in men with moderate-to-severe lower urinary...
Edited by: ES
